Health Condition 1: null- Chalazion
Conditions
Interventions
Intervention1: I & C WITH PERILESIONAL TRIAMCINOLONE INJECTION: Cases were operated using Incision and Curettage . at the time of surgery peri lesional triamcinolone was injected
Control Intervention1
Sponsors
Dr Shashi Vashisht
Eligibility
Inclusion criteria
Inclusion criteria: 1. Lid swelling which is clinically diagnosed as chalazion- a) Of at least one month duration b) Size >3 mm c) Not responding to conservative management for a minimum of 2 weeks. A lesion would be categorized clinically as chalazion based on the following diagnostic features: Firm painless swelling in either lid involving the tarsal plate, increasing gradually in size with no symptoms of inflammation. 2. Subject able and willing to participate in the study.
Exclusion criteria
Exclusion criteria: 1. Subject on anticoagulant which cannot be discontinued. 2. Ocular and periocular infection within 14 days prior to surgery. 3. Pregnant and breast feeding women. 4. Patient with known allergy to xylocaine or triamcinolone acetonide used in the study.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Lesion resolution measuring greater than 80%. Timepoint: Two weeks | — |
Secondary
| Measure | Time frame |
|---|---|
| 1. Period required for resolution of lesion. 2. Period required for resolution of inflammation. 3. Complications 4. Inflammation score at each visit. Timepoint: 1.Two weeks 2.Two weeks 3.Two weeks 4.Two weeks | — |
Countries
India
Contacts
Public ContactDr Niharika
PGIMER Dr RMLHospital
Outcome results
None listed